Anxiety
LUNESTA(R) Study Of Patients With Insomnia And Co-Morbid Generalized Anxiety Disorder (GAD) Published In Archives Of General Psychiatry - Sepracor Inc. (Nasdaq: SEPR) announced the publication of a study of LUNESTA tablets in patients with insomnia and co-morbid generalized anxiety disorder (GAD) in the May issue of the Archives of General Psychiatry. This 595-patient study examined the safety and efficacy of LUNESTA co-administered with escitalopram oxalate, which is commonly used in the treatment of anxiety, versus co-administration of escitalopram and placebo in patients with insomnia and co-existing GAD.
Alcohol Cravings In Response To Negative Emotions Felt More Acutely By Men - Women and men tend to have different types of stress-related psychological disorders. Women have greater rates of depression and some types of anxiety disorders than men, while men have greater rates of alcohol-use disorders than women. A new study of emotional and alcohol-craving responses to stress has found that when men become upset, they are more likely than women to want alcohol.
Next Pharmaceuticals Announces A New Clinical Study Demonstrating Relora(R) Significantly Relieves Short-Term Anxiety In Healthy Women - Next Pharmaceuticals announced the results of a six-week, double-blind, placebo-controlled clinical study on Relora conducted on healthy women between the ages of 20 and 50. Relora significantly reduced short-term anxiety compared to the placebo group. The study conducted by Miami Research Associates, a clinical research organization in Miami, Florida, was published in Nutrition Journal, an open access peer-reviewed, online journal.
Improving Anxiety Treatment Through The Help Of Brain Imaging: A Potential Future Treatment Strategy - Wouldn’t it be nice if our doctors could predict accurately whether we would respond to a particular medication? This question is important because research studies provide information about how groups of patients tend to respond to treatments, but inevitably, differences among groups of patients with the same diagnosis mean that findings about groups of patients may not apply to individuals from those groups.
Multicellular Response Is ‘All For One’ - Real or perceived threats can trigger the well-known “fight or flight response” in humans and other animals. Adrenaline flows, and the stressed individual’s heart pumps faster, the muscles work harder, the brain sharpens and non-essential systems shut down. The whole organism responds in concert in order to survive.
National Conference To Help Rural Veterans Cope With Combat Stress, Hosted By Geisinger - With the war in Iraq in its sixth year and a new generation of veterans requiring care, Geisinger Health System will host a conference May 13 that brings together military and civilian experts to better understand and meet the unique challenges faced by rural soldiers and their families.
Cancer Patients Put At Risk For PTSD By Anxiety And Mood Disorders - Breast cancer patients who have a prior history of mood and anxiety disorders are at a much higher risk of experiencing posttraumatic stress disorder following their diagnosis, new research suggests.A study of 74 breast cancer patients at the Ohio State University Medical Center found that 16 percent of them (12 women) suffered from PTSD 18 months after diagnosis.
The Psychological Cost Of Climbing Gas Prices - Rising gas prices are affecting more than the family budget. More pain at the pump results in more employee stress on the job, says Wayne Hochwarter, the Jim Moran Professor of Management at Florida State University’s College of Business.”People concerned with the effects of gas prices were significantly less attentive on the job, less excited about going to work, less passionate and conscientious and more tense,” Hochwarter said.
Seroquel Evaluation On Improvement In Short And Long-Term Symptoms - AstraZeneca (NYSE:AZN) announced new study data on SEROQUEL XR™ (quetiapine fumarate) Extended-Release Tablets (quetiapine XR) for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD) in adult patients. The results from the studies were presented today at the 161st Annual Meeting of the American Psychiatric Association (APA) in Washington, DC.
Alexza Completes Enrollment In Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) In Panic Disorder Patients - Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has completed the enrollment in its Phase 2a proof-of-concept clinical trial with AZ-002 (Staccato(R) alprazolam) in patients with panic disorder. AZ-002 is an inhalation product candidate being developed for the acute treatment of panic attacks associated with panic disorder. AZ-002 is being developed through Symphony Allegro, a development collaboration formed between Alexza and Symphony Capital in 2006.
Memory Manipulation Questioned By Moral Philosopher - Is medicated memory manipulation ethically sound? And perhaps more importantly, who should be charged with the decision to deliver such a treatment: patient or physician? Elisa Hurley, a philosophy professor, is seeking answers to these questions in her research currently underway at The University of Western Ontario.
Is Panic A Pharmaceutical Invention? - A paper by Giovanni A. Fava and associates of the University of Bologna published in the April issue of Psychotherapy and Psychosomatics summarizes the evidence which supports the seriousness of agoraphobia as an invalidating disease. At the same time it questions the excessive emphasis on panic which has been attributed in the past decade and the role of pharmaceutical industry in this attribution.
Social Form Of Bullying Linked To Depression, Anxiety In Adults - Spreading rumors and gossiping may not cause bruises or black eyes, but the psychological consequences of this social type of bullying could linger into early adulthood, a new University of Florida study shows.
How To Recognize The Signs And Symptoms Of Anxiety And Depressive Illnesses - Each year more than 40 million Americans will suffer from an anxiety disorder and more than 19 million Americans will suffer with a depressive illness. The most common signs of anxiety and depression include feelings of being down or blue, phobias, uncontrollable worrying, poor concentration, loss of pleasure, sleeping problems, panic attacks, unexplainable aches, pains or headaches, obsessions, rituals and ongoing feelings of nervousness or tension.
Depression, Post-Traumatic Stress Disorder Among Service Members Will Cost U.S. Up To $6.2B Over Two Years, According To Report - Nearly one in five, or about 300,000, soldiers who has served in Iraq or Afghanistan has post-traumatic stress disorder or major depression -- illnesses that could cost the U.S. as much as $6.2 billion over two years in care, lost productivity and lost lives through suicide, according to a RAND report released on Thursday, the
High Anxiety? - Right now, about half of all people who take medicine for an anxiety disorder don’t get much help from it. And doctors have no definitive way to predict who will, and who won’t, benefit from each anti anxiety prescription they write. But a University of Michigan Medical School researcher and his team are working to bring more certainty to how doctors and patients choose anxiety treatments, by probing the connection between brain activity, genetics and medication.
1 In 5 Iraq And Afghanistan Veterans Suffer From PTSD Or Major Depression - Nearly 20 percent of military service members who have returned from Iraq and Afghanistan -- 300,000 in all -- report symptoms of post traumatic stress disorder or major depression, yet only slight more than half have sought treatment, according to a new RAND Corporation study.
Lyrica Reduced Pain Of Fibromyalgia In Patients Regardless Of Symptoms Of Anxiety Or Depression - Pfizer’s Lyrica reduced pain of fibromyalgia in patients regardless of whether they experienced symptoms of anxiety or depression at the beginning of the study, according to a pooled analysis presented today at the American Academy of Neurology annual meeting.
BrainCells Inc. Initiates Phase 2 Clinical Trial With BCI-540 For Depression With Anxiety - BrainCells Inc. (BCI), a biopharmaceutical company utilizing its platform technology to identify and develop compounds that promote the growth of new neurons for the treatment of central nervous system (CNS) diseases, announced that it has initiated a Phase 2a clinical trial with its lead product candidate, BCI-540, for the treatment of depression with anxiety.
Mental Stress Reduces Blood Flow To The Heart In Patients With Gene Variation - University of Florida researchers have identified a gene variation in heart disease patients who appear especially vulnerable to the physical effects of mental stress - to the point where blood flow to the heart is greatly reduced. “Searching for the presence of this gene may be one way to better identify patients who are at an increased risk for the phenomenon,” said David S. Sheps, M.D.
Treating Post-Traumatic Stress First Helps Children Overcome Grief - Post traumatic stress disorder is commonly thought to effect victims of major trauma and those who witness violence, but a new University of Georgia study finds that it also can affect children who have lost a parent expectedly to diseases such as cancer.The finding, scheduled to be published in the May issue of the journal Research on Social Work Practice, has major implications for helping children cope with grief, said lead author Rene Searles McClatchey.
By Seeking Out Positive Experiences That Make Us Laugh We Can Do A Lot On Our Own To Stay Well - In 2006 researchers investigating the interaction between the brain, behavior, and the immune system found that simply anticipating a mirthful laughter experience boosted health-protecting hormones. Now, two years later, the same researchers have found that the anticipation of a positive humorous laughter experience also reduces potentially detrimental stress hormones. According to Dr.
Cocaine More Likely To Be Chosen Over Food By Subordinate Monkeys - Having a lower social standing increases the likelihood that a monkey faced with a stressful situation will choose cocaine over food, according to a study at Wake Forest University School of Medicine. More dominant monkeys undergoing the same stressful situation had fewer changes in brain activity in areas of the brain involved in stress and anxiety and were less likely to choose cocaine.Robert Warren Gould, a graduate student in the laboratory of Michael A. Nader, Ph.D.
Students Go It Alone Under Stress, Australia - Some university students are drowning in psychological distress and many are not seeking specialist help as new research shows the student life is not as carefree as it might appear. More than half the 384 students who attended one university health service at a large Queensland urban university last October, reported mild to very high levels of psychological distress, including depression and anxiety.
Study Shows A Little Anxiety Pays Sometimes - Anxiety gets a lot of bad press. Dwelling on the negative can lead to chronic stress and anxiety disorders and phobias, but evolutionarily speaking, anxiety holds some functional value. In humans, learning to avoid harm is necessary not only for surviving in the face of basic threats (such as predators or rotten food), but also for avoiding more complex social or economic threats (such as enemies or questionable investments).
